Copyright Reports & Markets. All rights reserved.

Global Non-Invasive Drug Delivery Device Market Research Report 2021

Request for Sample of this report
Buy now

1 Non-Invasive Drug Delivery Device Market Overview

  • 1.1 Product Overview and Scope of Non-Invasive Drug Delivery Device
  • 1.2 Non-Invasive Drug Delivery Device Segment by Type
    • 1.2.1 Global Non-Invasive Drug Delivery Device Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Liquid-Based Needle-Free Injector
    • 1.2.3 Powder-Based Needle-Free Injector
  • 1.3 Non-Invasive Drug Delivery Device Segment by Application
    • 1.3.1 Non-Invasive Drug Delivery Device Sales Comparison by Application: (2021-2027)
    • 1.3.2 Diabetes Management
    • 1.3.3 Vaccine Management
    • 1.3.4 Pain Management
    • 1.3.5 Respiratory Management
    • 1.3.6 Others
  • 1.4 Global Non-Invasive Drug Delivery Device Market Size Estimates and Forecasts
    • 1.4.1 Global Non-Invasive Drug Delivery Device Revenue 2016-2027
    • 1.4.2 Global Non-Invasive Drug Delivery Device Sales 2016-2027
    • 1.4.3 Non-Invasive Drug Delivery Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-Invasive Drug Delivery Device Market Competition by Manufacturers

  • 2.1 Global Non-Invasive Drug Delivery Device Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Non-Invasive Drug Delivery Device Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Non-Invasive Drug Delivery Device Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Non-Invasive Drug Delivery Device Manufacturing Sites, Area Served, Product Type
  • 2.5 Non-Invasive Drug Delivery Device Market Competitive Situation and Trends
    • 2.5.1 Non-Invasive Drug Delivery Device Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Non-Invasive Drug Delivery Device Players Market Share by Revenue
    • 2.5.3 Global Non-Invasive Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-Invasive Drug Delivery Device Retrospective Market Scenario by Region

  • 3.1 Global Non-Invasive Drug Delivery Device Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Non-Invasive Drug Delivery Device Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Non-Invasive Drug Delivery Device Market Facts & Figures by Country
    • 3.3.1 North America Non-Invasive Drug Delivery Device Sales by Country
    • 3.3.2 North America Non-Invasive Drug Delivery Device Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Non-Invasive Drug Delivery Device Market Facts & Figures by Country
    • 3.4.1 Europe Non-Invasive Drug Delivery Device Sales by Country
    • 3.4.2 Europe Non-Invasive Drug Delivery Device Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Non-Invasive Drug Delivery Device Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Non-Invasive Drug Delivery Device Sales by Region
    • 3.5.2 Asia Pacific Non-Invasive Drug Delivery Device Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Non-Invasive Drug Delivery Device Market Facts & Figures by Country
    • 3.6.1 Latin America Non-Invasive Drug Delivery Device Sales by Country
    • 3.6.2 Latin America Non-Invasive Drug Delivery Device Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Non-Invasive Drug Delivery Device Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Non-Invasive Drug Delivery Device Sales by Country
    • 3.7.2 Middle East and Africa Non-Invasive Drug Delivery Device Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Non-Invasive Drug Delivery Device Historic Market Analysis by Type

  • 4.1 Global Non-Invasive Drug Delivery Device Sales Market Share by Type (2016-2021)
  • 4.2 Global Non-Invasive Drug Delivery Device Revenue Market Share by Type (2016-2021)
  • 4.3 Global Non-Invasive Drug Delivery Device Price by Type (2016-2021)

5 Global Non-Invasive Drug Delivery Device Historic Market Analysis by Application

  • 5.1 Global Non-Invasive Drug Delivery Device Sales Market Share by Application (2016-2021)
  • 5.2 Global Non-Invasive Drug Delivery Device Revenue Market Share by Application (2016-2021)
  • 5.3 Global Non-Invasive Drug Delivery Device Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novartis AG
    • 6.1.1 Novartis AG Corporation Information
    • 6.1.2 Novartis AG Description and Business Overview
    • 6.1.3 Novartis AG Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novartis AG Product Portfolio
    • 6.1.5 Novartis AG Recent Developments/Updates
  • 6.2 Inovio Pharmaceuticals, Inc.
    • 6.2.1 Inovio Pharmaceuticals, Inc. Corporation Information
    • 6.2.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
    • 6.2.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Inovio Pharmaceuticals, Inc. Product Portfolio
    • 6.2.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates
  • 6.3 Medtronic Plc.
    • 6.3.1 Medtronic Plc. Corporation Information
    • 6.3.2 Medtronic Plc. Description and Business Overview
    • 6.3.3 Medtronic Plc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Medtronic Plc. Product Portfolio
    • 6.3.5 Medtronic Plc. Recent Developments/Updates
  • 6.4 Tandem Diabetes Care, Inc.
    • 6.4.1 Tandem Diabetes Care, Inc. Corporation Information
    • 6.4.2 Tandem Diabetes Care, Inc. Description and Business Overview
    • 6.4.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Tandem Diabetes Care, Inc. Product Portfolio
    • 6.4.5 Tandem Diabetes Care, Inc. Recent Developments/Updates
  • 6.5 Teva Pharmaceutical Industries Ltd.
    • 6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
    • 6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
    • 6.5.3 Teva Pharmaceutical Industries Ltd. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Teva Pharmaceutical Industries Ltd. Product Portfolio
    • 6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 6.6 Crossject Medical Technology
    • 6.6.1 Crossject Medical Technology Corporation Information
    • 6.6.2 Crossject Medical Technology Description and Business Overview
    • 6.6.3 Crossject Medical Technology Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Crossject Medical Technology Product Portfolio
    • 6.6.5 Crossject Medical Technology Recent Developments/Updates
  • 6.7 Adherium Ltd.
    • 6.6.1 Adherium Ltd. Corporation Information
    • 6.6.2 Adherium Ltd. Description and Business Overview
    • 6.6.3 Adherium Ltd. Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Adherium Ltd. Product Portfolio
    • 6.7.5 Adherium Ltd. Recent Developments/Updates
  • 6.8 Sensirion AG
    • 6.8.1 Sensirion AG Corporation Information
    • 6.8.2 Sensirion AG Description and Business Overview
    • 6.8.3 Sensirion AG Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Sensirion AG Product Portfolio
    • 6.8.5 Sensirion AG Recent Developments/Updates
  • 6.9 Diabeloop
    • 6.9.1 Diabeloop Corporation Information
    • 6.9.2 Diabeloop Description and Business Overview
    • 6.9.3 Diabeloop Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Diabeloop Product Portfolio
    • 6.9.5 Diabeloop Recent Developments/Updates
  • 6.10 PharmaJet
    • 6.10.1 PharmaJet Corporation Information
    • 6.10.2 PharmaJet Description and Business Overview
    • 6.10.3 PharmaJet Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 PharmaJet Product Portfolio
    • 6.10.5 PharmaJet Recent Developments/Updates
  • 6.11 PenJet
    • 6.11.1 PenJet Corporation Information
    • 6.11.2 PenJet Non-Invasive Drug Delivery Device Description and Business Overview
    • 6.11.3 PenJet Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 PenJet Product Portfolio
    • 6.11.5 PenJet Recent Developments/Updates
  • 6.12 Portal Instruments
    • 6.12.1 Portal Instruments Corporation Information
    • 6.12.2 Portal Instruments Non-Invasive Drug Delivery Device Description and Business Overview
    • 6.12.3 Portal Instruments Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Portal Instruments Product Portfolio
    • 6.12.5 Portal Instruments Recent Developments/Updates
  • 6.13 Capsule Technologies
    • 6.13.1 Capsule Technologies Corporation Information
    • 6.13.2 Capsule Technologies Non-Invasive Drug Delivery Device Description and Business Overview
    • 6.13.3 Capsule Technologies Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Capsule Technologies Product Portfolio
    • 6.13.5 Capsule Technologies Recent Developments/Updates
  • 6.14 Propeller Health
    • 6.14.1 Propeller Health Corporation Information
    • 6.14.2 Propeller Health Non-Invasive Drug Delivery Device Description and Business Overview
    • 6.14.3 Propeller Health Non-Invasive Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Propeller Health Product Portfolio
    • 6.14.5 Propeller Health Recent Developments/Updates

7 Non-Invasive Drug Delivery Device Manufacturing Cost Analysis

  • 7.1 Non-Invasive Drug Delivery Device Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Non-Invasive Drug Delivery Device
  • 7.4 Non-Invasive Drug Delivery Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Non-Invasive Drug Delivery Device Distributors List
  • 8.3 Non-Invasive Drug Delivery Device Customers

9 Non-Invasive Drug Delivery Device Market Dynamics

  • 9.1 Non-Invasive Drug Delivery Device Industry Trends
  • 9.2 Non-Invasive Drug Delivery Device Growth Drivers
  • 9.3 Non-Invasive Drug Delivery Device Market Challenges
  • 9.4 Non-Invasive Drug Delivery Device Market Restraints

10 Global Market Forecast

  • 10.1 Non-Invasive Drug Delivery Device Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Non-Invasive Drug Delivery Device by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Non-Invasive Drug Delivery Device by Type (2022-2027)
  • 10.2 Non-Invasive Drug Delivery Device Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Non-Invasive Drug Delivery Device by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Non-Invasive Drug Delivery Device by Application (2022-2027)
  • 10.3 Non-Invasive Drug Delivery Device Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Non-Invasive Drug Delivery Device by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Non-Invasive Drug Delivery Device by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Liquid-Based Needle-Free Injector
    Powder-Based Needle-Free Injector

    Segment by Application
    Diabetes Management
    Vaccine Management
    Pain Management
    Respiratory Management
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Novartis AG
    Inovio Pharmaceuticals, Inc.
    Medtronic Plc.
    Tandem Diabetes Care, Inc.
    Teva Pharmaceutical Industries Ltd.
    Crossject Medical Technology
    Adherium Ltd.
    Sensirion AG
    Diabeloop
    PharmaJet
    PenJet
    Portal Instruments
    Capsule Technologies
    Propeller Health

    Buy now